Kavalactone pharmacophores for major cellular drug targets.

@article{Rowe2011KavalactonePF,
  title={Kavalactone pharmacophores for major cellular drug targets.},
  author={A. Rowe and R. Narlawar and P. Groundwater and I. Ramzan},
  journal={Mini reviews in medicinal chemistry},
  year={2011},
  volume={11 1},
  pages={
          79-83
        }
}
  • A. Rowe, R. Narlawar, +1 author I. Ramzan
  • Published 2011
  • Biology, Medicine
  • Mini reviews in medicinal chemistry
  • A number of studies have identified differential kavalactone activity against a variety of molecular targets, including P-glycoprotein (Pgp), platelet monoamine oxidase (MAO-B), transcription factor binding domains, pregnane X (PXR) and GABA receptors, and cytochrome P450 and cyclo-oxygenase (COX) enzymes. The molecular structure of the kavalactones possesses a pharmacophore for several of these targets. In most cases, conformational stability is more significant than the substituents present… CONTINUE READING
    8 Citations
    Pharmacophore modeling for antitargets.
    • 7
    Neuroprotective properties of kavalactones
    • 11
    • Highly Influenced
    Updates on Nutraceutical Sleep Therapeutics and Investigational Research
    • 11
    • PDF